Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Cellular Biomedicine Group, Inc.
| Metric | Cellular Biomedicine Group, Inc. Healthcare |
|---|---|
| Quality Score | 22 / 100 |
| Revenue (latest) | $49,265 |
| Net income (latest) | −$9M |
| Operating margin | −19114.8% |
| Net margin | −18952.2% |
| Return on equity | −16.8% |
| Return on assets | −9.6% |
| Return on capital (ROCE) | −12.8% |
| Debt / equity | 0.75× |
| Revenue growth (YoY) | −3.3% |
| Altman Z″ (distress) | -5.24 |
| Accruals / assets | 31.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.